2024 RNA Insights and Trends

Tracking market trends to over time to predict the future landscape and spot opportunities is crucial for both biopharma and service providers.

Biopharmas must ensure they are ‘one step ahead’ in an extremely competitive market and de-risk decisions.

Service providers need to respond early to shifting demands, changing client needs to make smart investment decisions.

This analysis investigates key trends in delivery system preferences revealing what the RNA pipeline is most likely to look like in future

These insights and market knowledge have been developed based on the analysis and fusion of data collated from a variety of sources by the Hanson Wade Intelligence team, elevating the quality of insights compared to Beacon data alone:

• Beacon RNA database: Vast repository of highly granular, current and historical data on delivery systems used by RNA assets; exploration by the Hanson Wade Intelligence of its deepest recesses and use of smart interpretation facilitates in-depth understanding of trends and trajectories at quantitative scale, and over long time periods

• Interviews with leading KOLs: Opinions from leading experts in the field of RNA provided deep understanding of the ‘whys’ driving the ‘what’s’ sitting within Beacon. One-to-one conversations with the Hanson Wade Intelligence team is the perfect environment for honest, unbiased views where they can tell you what they ‘really think’ about the future market

• External sources: Datapoints from additional external sources were used to complement existing Beacon data; clever inference and data fusion was used to increase the relevance and meaning of the outputs, enabling a higher quality of insights.